Direct-acting Antivirals (IMAGE)

University of Montreal Hospital Research Centre (CRCHUM)

Direct-acting Antivirals

Caption

More than 85% of Canadian provinces and territories restrict access to new direct-acting antivirals (DAA) for the treatment of the hepatitis C.

Credit

CHUM

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.